GILEAD SCIENCES IRELAND UNLIMITED COMPANY

Gilead Sciences Ireland Unlimited Company is a leading biopharmaceutical organisation dedicated to tackling some of the world's most serious diseases. Through cutting-edge research and a commitment to health equity, Gilead develops and delivers transformative therapies across three core therapeutic areas: virology, oncology and inflammation. Its global portfolio of medicines and robust clinical programmes aim to improve the lives of patients and communities worldwide.

The company's deep, diverse pipeline reflects a focus on innovative science, with ongoing work in viral infections, cancer treatments and inflammatory conditions. In addition to its drug development activities, Gilead funds philanthropic HIV programmes in the United States, underscoring its broader commitment to public health. An inclusive workplace culture encourages employees to advance scientific innovation, ensure medicines reach those who need them, and make a positive impact in the communities where they work.